Clinical Trial Update: TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TCR alpha/beta T-cell-depleted haploidentical hematopoietic cell transplantation in children with primary immunodeficiency dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disorders
• Inherited Metabolic Disorders

Drugs mentioned

• TCR Alpha Beta T-cell Depleted Haploidentical Hematopoietic Cell Transplantation

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Primary Immune Deficiency Disorders, Metabolic Disease | Phase 2 | Status: RECRUITING